Ginsenoside compound K reduces neuronal damage and improves neuronal synaptic dysfunction by targeting Aβ

Background: Alzheimer’s disease (AD) is the most common neurodegenerative condition worldwide, with amyloid ß (Aβ) fibrils presenting as its main pathological feature. This study investigated whether Ginsenoside Compound K (CK) has activity against Aβ and its mechanism in reducing synaptic damage an...

Full description

Bibliographic Details
Main Authors: Na Li, Qihang Pang, Yanhong Zhang, Jianan Lin, Hui Li, Zhen Li, Yaxin Liu, Xingyu Fang, Yu An, Haonan Bai, Dianyu Li, Zhanhong Cao, Jian Liu, Qing Yang, Shaodan Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1103012/full